| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-20 22:13:14 UTC |
|---|
| Update Date | 2023-02-21 17:15:48 UTC |
|---|
| HMDB ID | HMDB0001645 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | L-Norleucine |
|---|
| Description | L-Norleucine, also known as L-aminohexanoate or caprine, belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. Thus, L-norleucine is considered to be a fatty acid lipid molecule. An unnatural amino acid that is used experimentally to study protein structure and function. L-Norleucine is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. L-Norleucine exists in all eukaryotes, ranging from yeast to humans. Outside of the human body, L-Norleucine has been detected, but not quantified in cow milk. This could make L-norleucine a potential biomarker for the consumption of these foods. It binds reversibly to the kringle domain of plasminogen and blocks the binding of plasminogen to fibrin and its activation to plasmin. |
|---|
| Structure | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-2-Aminohexanoic acid | ChEBI | | 2-Aminocaproic acid | ChEBI | | 2-Aminohexanoic acid | ChEBI | | alpha-Aminocaproic acid | ChEBI | | Caprine | ChEBI | | Glycoleucine | ChEBI | | L(+)-Norleucine | ChEBI | | L-(+)-Norleucine | ChEBI | | L-2-Aminohexanoate | ChEBI | | L-2-Aminohexanoic acid | ChEBI | | L-Aminohexanoate | ChEBI | | L-Aminohexanoic acid | ChEBI | | Nle | ChEBI | | Norleucine | ChEBI | | (S)-2-Aminohexanoate | Generator | | 2-Aminocaproate | Generator | | 2-Aminohexanoate | Generator | | a-Aminocaproate | Generator | | a-Aminocaproic acid | Generator | | alpha-Aminocaproate | Generator | | Α-aminocaproate | Generator | | Α-aminocaproic acid | Generator | | (S)-2-amino-Hexanoate | HMDB | | (S)-2-amino-Hexanoic acid | HMDB | | (S)-Aminohexanoate | HMDB | | (S)-Aminohexanoic acid | HMDB | | (S)-Norleucine | HMDB | | L-Isomer norleucine | MeSH, HMDB | | Norleucine, L isomer | MeSH, HMDB | | Norleucine, L-isomer | MeSH, HMDB | | 2S-Amino-hexanoate | Generator, HMDB |
|
|---|
| Chemical Formula | C6H13NO2 |
|---|
| Average Molecular Weight | 131.1729 |
|---|
| Monoisotopic Molecular Weight | 131.094628665 |
|---|
| IUPAC Name | (2S)-2-aminohexanoic acid |
|---|
| Traditional Name | caprine |
|---|
| CAS Registry Number | 327-57-1 |
|---|
| SMILES | CCCC[C@H](N)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 |
|---|
| InChI Key | LRQKBLKVPFOOQJ-YFKPBYRVSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | L-alpha-amino acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - L-alpha-amino acid
- Medium-chain fatty acid
- Amino fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | 234.00 °C. @ 760.00 mm Hg (est) | The Good Scents Company Information System | | Water Solubility | 12 mg/mL at 25 °C | Not Available | | LogP | -1.53 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.52 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.0631 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.67 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 320.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 765.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 320.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 84.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 187.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 81.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 289.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 281.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 613.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 708.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 157.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 815.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 186.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 234.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 623.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 383.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 258.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| L-Norleucine,1TMS,isomer #1 | CCCC[C@H](N)C(=O)O[Si](C)(C)C | 1198.1 | Semi standard non polar | 33892256 | | L-Norleucine,1TMS,isomer #2 | CCCC[C@H](N[Si](C)(C)C)C(=O)O | 1287.3 | Semi standard non polar | 33892256 | | L-Norleucine,2TMS,isomer #1 | CCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1323.0 | Semi standard non polar | 33892256 | | L-Norleucine,2TMS,isomer #1 | CCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1359.1 | Standard non polar | 33892256 | | L-Norleucine,2TMS,isomer #1 | CCCC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1475.7 | Standard polar | 33892256 | | L-Norleucine,2TMS,isomer #2 | CCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1454.7 | Semi standard non polar | 33892256 | | L-Norleucine,2TMS,isomer #2 | CCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1393.3 | Standard non polar | 33892256 | | L-Norleucine,2TMS,isomer #2 | CCCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1636.2 | Standard polar | 33892256 | | L-Norleucine,3TMS,isomer #1 | CCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1517.0 | Semi standard non polar | 33892256 | | L-Norleucine,3TMS,isomer #1 | CCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1482.7 | Standard non polar | 33892256 | | L-Norleucine,3TMS,isomer #1 | CCCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1466.8 | Standard polar | 33892256 | | L-Norleucine,1TBDMS,isomer #1 | CCCC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1422.0 | Semi standard non polar | 33892256 | | L-Norleucine,1TBDMS,isomer #2 | CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1517.6 | Semi standard non polar | 33892256 | | L-Norleucine,2TBDMS,isomer #1 | CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1769.0 | Semi standard non polar | 33892256 | | L-Norleucine,2TBDMS,isomer #1 | CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1759.6 | Standard non polar | 33892256 | | L-Norleucine,2TBDMS,isomer #1 | CCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1770.4 | Standard polar | 33892256 | | L-Norleucine,2TBDMS,isomer #2 | CCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1882.1 | Semi standard non polar | 33892256 | | L-Norleucine,2TBDMS,isomer #2 | CCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1820.2 | Standard non polar | 33892256 | | L-Norleucine,2TBDMS,isomer #2 | CCCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1845.4 | Standard polar | 33892256 | | L-Norleucine,3TBDMS,isomer #1 | CCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2187.6 | Semi standard non polar | 33892256 | | L-Norleucine,3TBDMS,isomer #1 | CCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2083.7 | Standard non polar | 33892256 | | L-Norleucine,3TBDMS,isomer #1 | CCCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1885.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0a4i-0900000000-b9e660e9ed085e0a2756 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0a4i-0900000000-363d31fc4a3b15b97b49 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-000i-9200000000-786e1c364f918e406c7f | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-0a4i-0900000000-7c99693c3cc849290ecd | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-05fr-8900000000-3cf84aa3585ea0262b9a | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-MS (1 TMS) | splash10-000i-9200000000-d5ef9dd4b8be3c55a58f | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-MS (2 TMS) | splash10-0a4i-0900000000-df2e472e3bd858c871d0 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-MS (3 TMS) | splash10-001i-0391000000-a01428088011045cef83 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine EI-B (Non-derivatized) | splash10-000i-9100000000-1fddf89f6ec7f4b5cfbe | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine EI-B (Non-derivatized) | splash10-0a4i-0910000000-5eb6c8571ebbad86fac9 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0900000000-b9e660e9ed085e0a2756 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0900000000-363d31fc4a3b15b97b49 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Non-derivatized) | splash10-000i-9200000000-786e1c364f918e406c7f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-EI-TOF (Non-derivatized) | splash10-05fr-8900000000-3cf84aa3585ea0262b9a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-MS (Non-derivatized) | splash10-0a4i-0900000000-df2e472e3bd858c871d0 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-MS (Non-derivatized) | splash10-001i-0391000000-a01428088011045cef83 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Norleucine GC-MS (Non-derivatized) | splash10-000i-9200000000-d5ef9dd4b8be3c55a58f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Norleucine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00bl-9000000000-201d4196a590a77910e6 | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Norleucine GC-MS (1 TMS) - 70eV, Positive | splash10-00dl-9400000000-10c311ca7a06deeb972a | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Norleucine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Norleucine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-9100000000-b124c751376d5dfa51a5 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00ku-9000000000-734efe7e83b2a5a46f00 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9000000000-ac9b87f3b366d1310113 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-001i-0900000000-6cc58ea175a3d1492868 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-001i-0900000000-95aa6e4bfc4283439983 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-004i-3900000000-b75779678a92cd599f0c | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0019-9800000000-ee386f888d7ea62be255 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-000i-9000000000-93d53170f5b18b6e157c | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-00kr-9000000000-8abbc9ef83fc8fdd973c | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0006-9000000000-39712cf46e67bc1458fb | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-0006-9000000000-219a42048a733f3d5a23 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-000i-9000000000-2d321cebc7950b90d6b1 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive-QTOF | splash10-00kr-9200000000-916e946734d7c51678df | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-001i-0900000000-bc56a19fa8c09e226543 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ , negative-QTOF | splash10-001i-0900000000-6cc58ea175a3d1492868 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ , negative-QTOF | splash10-001i-0900000000-95aa6e4bfc4283439983 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QQ , negative-QTOF | splash10-004i-3900000000-b75779678a92cd599f0c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine LC-ESI-QTOF , negative-QTOF | splash10-001i-0900000000-bc56a19fa8c09e226543 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Norleucine , negative-QTOF | splash10-001i-0900000000-092c22a76d9d673f6ef9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Norleucine 10V, Positive-QTOF | splash10-0019-9600000000-d20978980da1f4122a43 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Norleucine 20V, Positive-QTOF | splash10-000i-9000000000-e402468856ebe93f5632 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Norleucine 40V, Positive-QTOF | splash10-0a4l-9000000000-323f487cfafb31db8c07 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Norleucine 10V, Negative-QTOF | splash10-001i-1900000000-87cdc1a1d627629c2d67 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Norleucine 20V, Negative-QTOF | splash10-001i-6900000000-7bd938134b1765555ef2 | 2016-09-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Norleucine 40V, Negative-QTOF | splash10-00di-9000000000-721ed018b3aaa7a7d07d | 2016-09-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|